Epharmix, a St. Louis-based health technology startup created by a team of recent Wash U alumni, including Joe McDonald, MBA’15, medical students and physicians  has raised $765,000 from a group of five investors according to a report in the St. Louis Business Journal, July 28, 2015.

Epharmix creates condition-specific digital interventions for medical care that provide follow up care via texting messages and other contact with patients.

Founders include WashU alumni: Blake Marggraff (CEO); Avik Som (CMO); Evan Huang (CTO); and Joe McDonald (COO and CFO). Epharmix also has a team of advisors that includes Dr. Will Ross, a nephrologist and associate dean for diversity and assistant professor of medicine at WUSM.